Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2018 Nov;16(5):5791-5798.
doi: 10.3892/ol.2018.9394. Epub 2018 Sep 4.

Trends of incidence and survival in patients with gastrointestinal mucinous adenocarcinoma

Zhen Zong  1 , Yonghui Luo  1 , Houqun Ying  2 , Anan Wang  1 , Hui Li  3 , Chenghao Yi  1
Affiliations

Trends of incidence and survival in patients with gastrointestinal mucinous adenocarcinoma

Zhen Zong et al. Oncol Lett. 2018 Nov.

Abstract

The epidemiology and clinical outcome of gastrointestinal mucinous adenocarcinoma (MA) are not well illustrated. The present study aimed to explore the evolving epidemiology and prognostic factors that affect the survival of patients with MA in the gastrointestinal tract. A retrospective and population-based study was conducted to determine the annual age-adjusted incidence, overall survival (OS) and survival trend of gastrointestinal mucinous MA using nationally representative data from the Surveillance, Epidemiology, and End Results (SEER) program between 2000 and 2014. A Kaplan-Meier curve and a Cox proportional regression model were used to evaluate prognostic factors for this disease. Of the 51632 cases, females accounted for 50.5% (26058). The annual incidence of MA steadily decreased from 2000 to 2014. This trend occurred across all stages, grades and sites, apart from the appendix. In the SEER 18 registry grouping (2000-2014), the highest incidence was 3.333 per 100,000 persons for the colon. The median OS varied significantly between different primary sites, stages, grades, and age of clinical diagnosis, and the time period of diagnosis, according to a multivariable analysis. The five-year OS of gastrointestinal MA improved gradually between 2000 and 2014. The improvement in survival over the same interval was more pronounced in the subgroup of distant gastrointestinal MA. All sites along the alimentary tract, with the exception of the appendix, showed a decrease in the incidence of MA. Improved survival rates were observed for most of the gastrointestinal tract, especially for patients with advanced stage disease. MA in the upper gastrointestinal tract was less frequent but had poorer survival than colorectal MA. Clinicians should consider the primary tumour site when making therapeutic guidelines and treatment decisions for gastrointestinal MA.

Keywords: SEER database; gastrointestinal mucinous adenocarcinoma; incidence; survival.

PubMed Disclaimer

Figures

Figure 1.
Figure 1.
Incidence trends of gastrointestinal mucinous adenocarcinoma from 2000 to 2014.
Figure 2.
Figure 2.
Incidence trends of gastrointestinal mucinous adenocarcinoma by site and grade from 2000 to 2014. (A) Incidence trends of gastrointestinal mucinous adenocarcinoma by site from 2000 to 2014. (B) Incidence trends of gastrointestinal mucinous adenocarcinoma by grade from 2000 to 2014. GIMC, gastrointestinal mucinous carcinoma.
Figure 3.
Figure 3.
Median OS of gastrointestinal mucinous adenocarcinoma. (A) Median OS of gastrointestinal mucinous adenocarcinoma by site. (B) Median OS of gastrointestinal mucinous adenocarcinoma by grade. OS, overall survival.
Figure 4.
Figure 4.
Five year OS of gastrointestinal mucinous carcinoma by stage and year. OS, overall survival.
See this image and copyright information in PMC

References

    1. Siegel RL, Miller KD, Jemal A. Cancer Statistics, 2017. CA Cancer J Clin. 2017;67:7–30. doi: 10.3322/caac.21387. - DOI - PubMed
    1. Nitsche U, Zimmermann A, Späth C, Muller T, Maak M, Schuster T, Slotta-Huspenina J, Kaser SA, Michalski CW, Janssen KP, et al. Mucinous and signet-ring cell colorectal cancers differ from classical adenocarcinomas in tumor biology and prognosis. Ann Surg. 2013;258:775–783. doi: 10.1097/SLA.0b013e3182a69f7e. - DOI - PMC - PubMed
    1. Jass JR, Sobin LH, Watanabe H. The World Health Organization's histologic classification of gastrointestinal tumors. A commentary on the second edition. Cancer. 1990;66:2162–2167. doi: 10.1002/1097-0142(19901115)66:10<2162::AID-CNCR2820661020>3.0.CO;2-N. - DOI - PubMed
    1. Pihl E, Nairn RC, Hughes ES, Cuthbertson AM, Rollo AJ. Mucinous colorectal carcinoma: Immunopathology and prognosis. Pathology. 1980;12:439–447. doi: 10.3109/00313028009077107. - DOI - PubMed
    1. Hugen N, Brown G, Glynne-Jones R, de Wilt JH, Nagtegaal ID. Advances in the care of patients with mucinous colorectal cancer. Nat Rev Clin Oncol. 2016;13:361–369. doi: 10.1038/nrclinonc.2015.140. - DOI - PubMed